FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is, by far, the most prevalent and fatal kind of kidney cancer. Ferrochelatase (FECH) is an enzyme that performs a significant function in the onset and progression of many distinct kinds of malignant tumors. Nevertheless, its predictive usefulness...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Guanghui, Li, Qing, Luo, Yang, Liu, Yufeng, Liu, Dawei, li, Bin, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436586/
https://www.ncbi.nlm.nih.gov/pubmed/36059798
http://dx.doi.org/10.1155/2022/8943643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436586/
https://www.ncbi.nlm.nih.gov/pubmed/36059798
http://dx.doi.org/10.1155/2022/8943643

Ejemplares similares